Search

everythinglearnresearchcommunity

for

Search:↓

More people are using online platforms for hair loss treatment due to convenience and privacy.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Digital health platforms improve treatment for male pattern hair loss.

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

People often have negative attitudes toward those with alopecia, especially if it's severe or seen as a medical issue.

A male with aromatase deficiency improved bone health with estradiol treatment.

The document is a detailed medical reference on skin and genetic disorders.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

More severe alopecia areata can lower quality of life.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

A new mutation in the KRT86 gene was found to cause the hair disorder monilethrix in a Han family.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

The Brigham Eyebrow Tool for Alopecia is a simple and reliable way to measure eyebrow hair loss.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

People with alopecia who are more resilient tend to feel less stressed.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Alopecia areata and its severe forms are becoming more common, especially among females, adults, and people in the Northeast.